CTLA4 and melanoma: Most prominently, melanoma patients bearing liver metastasis have reduced CTLA-4 and PD-1 co-expression in CD8+ T cells (164), which has been shown to stratify therapeutic response to immune checkpoint inhibitor treatment (166).